| Volume: 39 Suppl: 4 - October 2011 | |
| Show Abstracts | << Back | |
| 1. | The current status of cardiovascular risk factors in Turkey Adnan Abacı doi: 10.5543/tkda.2011.abaci Pages 1 - 5 Abstract | Full Text PDF (Article in Turkish) |
| 2. | Methods of risk estimation for cardiovascular disease Hakan Kültürsay doi: 10.5543/tkda.2011.kultursay Pages 6 - 13 Abstract | Full Text PDF (Article in Turkish) |
| 3. | Treatment of dyslipidemia in primary prevention and rosuvastatin Fatih Sinan Ertaş doi: 10.5543/tkda.2011.ertas Pages 14 - 18 Abstract | Full Text PDF (Article in Turkish) |
| 4. | Translation: [Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk ≥5% or Framingham risk >20%: post hoc analyses of the JUPITER trial requested by European health authorities] Pages 19 - 28 Abstract | Full Text PDF (Article in Turkish) |